Lysophosphatidic Acid Receptor 3 (EDG-7)

For use as a positive control with Exalpha's EDG7 monoclonal antibody (Cat. No. X1183P) for Western blot analysis.

Endothelial Cell Differentiation Gene-7 (EDG7) belongs to a family of G-protein coupled receptors whose ligands are lysophospholipids. The ligand for EDG7 is lysophospholipid. There are 8 known members of the EDG receptor family and they are implicated in mediating growth related effects such as induction of cellular proliferation, alterations in differentiation and survival and suppression of apoptosis. They also evoke cellular effector functions that are dependent on cytoskeletal responses such as contraction, secretion, adhesion and chemotaxis. EDG receptors are developmentally regulated and differ in tissue distribution. They couple to multiple types of G proteins to signal through ras and MAP kinase, rho, phospholipase C and several protein tyrosine kinases. EDG7 is expressed in prostate as well as other tissues.

This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals.

See vial for concentration

Ancillary Reagents

Provided in 10% glycerol, 0.063 M Tris-HCl (pH 6.8), 2% SDS and 0.002% bromophenol blue, 5% 2-mercaptoethanol

Western Blotting

Unconjugated

Products are stable for one year from purchase when stored properly

EDG7 (LPA3) Transfected Cell Positive Control Lysate